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ABSTRACT
Aberrant mRNAs whose open reading frame (ORF)
is truncated by the presence of a premature
translation-termination codon (PTC) are recognized
and degraded in eukaryotic cells by a process called
nonsense-mediated mRNA decay (NMD). Here, we
report the development of a reporter system that
allows monitoring of NMD in mammalian cells by
measuring the fluorescence of green fluorescent
protein (GFP). The NMD reporter gene consists of
a T-cell receptor-b minigene construct, in which the
GFP-ORF was inserted such that the stop codon
of GFP is recognized as PTC. The reporter mRNA
is therefore subjected to NMD, resulting in a low
steady-state mRNA level, an accordingly low protein
level and hence a very low green fluorescence in
normal, NMD-competent cells that express this
reporter gene. We show that the inactivation of NMD
by RNAi-mediated knockdown of the essential NMD
factor hUpf1 or hSmg6 increases the NMD reporter
mRNA level, resulting in a proportional increase
of the green fluorescence that can be detected by
flowcytometry,spectrofluorometryandfluorescence
microscopy. With these properties, our GFP-based
NMD reporter system could be used for large-scale
screenings to identify NMD-inhibiting drugs or NMD-
deficient mutant cells.
INTRODUCTION
Quality control checkpoints at different stages during gene
expression are necessary to keep production of aberrant gene
products low and thus to allow proper functioning of the cells.
On the post-transcriptional level, a process called nonsense-
mediated mRNA decay (NMD) has evolved in all eukaryotes
examined so far to recognize and speciﬁcally degrade aberrant
mRNAs, in which the open reading frame (ORF) is truncated
by the presence of a premature translation-termination
codon (PTC) (1). Two important sources giving rise to PTC-
containing mRNAs (PTC+ mRNAs) in metazoans are muta-
tions in the DNA and pre-mRNA splicing. It is estimated that
about one-third of all inherited genetic disorders and many
forms of cancer are caused by mutations that result in the gen-
eration of PTC+ mRNA (2). In humans, more than half of all
pre-mRNAs undergo alternative splicing (3), and about one-
third of these alternative transcripts contain a PTC (4). This
demonstrates that NMD is an important cellular process that
prevents(oratleastreduces)theproductionofpotentiallydele-
terious truncated proteins and thereby modulates the clinical
manifestations of many genetic diseases (2,5,6). In addition,
immunoglobulin and T-cell receptor (TCR) genes more often
thannotacquirePTCsduringtheprogrammedV(D)Jrearrange-
ments which take place during lymphocyte maturation (7).
The molecular mechanisms underlying NMD are not well
understood. Seven different NMD factors have been genetic-
ally identiﬁed in Caenorhabditis elegans (8,9), and the ortho-
logues of three of them have also been genetically identiﬁed in
Saccharomyces cerevisiae (10,11). The orthologue genes in
humans, mice and Drosophila have all been found by homo-
logysearches (12–20).Owing tothe lackoffunctionalscreens,
putative mammalian NMD factors without orthologues in a
genetically amenable organism are therefore still awaiting
their discovery. It seems likely that additional, yet unknown,
NMD factors might exist in vertebrates, considering that NMD
appears to be more regulated and more sophisticated in more
complex organisms. For example, hUpf1 activity appears to be
regulated by a cycle of phosphorylation and dephosphoryla-
tion in metazoans, while S.cerevisiae lacks the orthologues
involved in regulating hUpf1’s phosphorylation state (1). Of
interest for this study, the human orthologue of C.elegans
SMG6, hSmg6, functions in dephosphorylation of hUpf1
(20) and is required for NMD (19). In addition, hSmg6 was
also found to associate with telomerase and its overexpression
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doi:10.1093/nar/gni052uncaps telomeres (18). Also consistent with the idea of more
factors being involved in NMD of more complex organisms,
several factors of the exon junction complex were found to
play a role in human NMD (21–25), while in Drosophila, the
exon junction complex is dispensable for NMD (19).
Although technically quite demanding, mutagenesis screens
in diploid human cells have been shown to be feasible (26,27),
provided a suitable reporter system is available. To study
mammalian NMD, several genes with PTCs at various posi-
tions were established as ‘model systems’ (28–32). But since
the analysis of NMD of these genes requires analysis of
mRNA, they are not suitable as reporters for screens. We,
therefore, decided to develop a NMD reporter system where
the readout was based on ﬂuorescence in intact cells or whole
cell extracts. We ﬁgured that such a NMD reporter system
would not only be a valuable tool for basic research but could
also be useful for drug screening. Given the large number of
genetic diseases originating from PTC-causing mutations,
there is also a considerable pharmaceutical interest to develop
substances that interfere with NMD. Here, we describe the
construction and characterization of a green ﬂuorescent pro-
tein (GFP)-based NMD reporter system that allows detection
of NMD-deﬁcient cells by the detection of increased green
ﬂuorescence. We show that this NMD reporter system can be
used in conjunction with ﬂow cytometry, spectroﬂuorometry
and ﬂuorescence microscopy.
MATERIAL AND METHODS
Plasmids
The parental vector expressing the TCR-b minigene (pb433)
has been described previously (33). pb510 was generated from
pb433 by replacing the NotI–SalI fragment with a double-
stranded oligo (50-gcGGCCGCGGCGGCGCCCTATAAAA-
CCCAGCGGCGCGACGCGCCACCACCGCCGAGACCG-
GTACCGtcgac-30; sequence of forward oligo is in upper case,
NotI and SalI sites in italics, transcription start site under-
lined), which creates an intronless 50-untranslated region
of 62 bp. The EGFP ORF was PCR ampliﬁed using primers
50-ATCTATAGCATATGCCATGGTGAGCAAGGGCGAG-30
and 50-ATCGACACCATATGCTCAGTACTTGTACAGCT-
CGTCCATGC-30 (NdeI site in italics, stop codon underlined),
digested with NdeI and inserted into the NdeI site of pb510.
Finally, the leader exon sequence was exchanged for a
sequence encoding the haemagglutinin A epitope by replacing
the SalI–EcoRI fragment with a double-stranded oligo
(50-gTCGACACCATGGCCTACCCATATGATGTTCCAGA-
TTACGCTTCACTCGAACGCGTAAGTGAGTGCTGGTC-
AGGCCACTGGTGTGCTTTCTTTTTTTAGaattc-30;s e q u e n c e
of forward oligo is in upper case, SalI and EcoRI sites in
italics, translation start site underlined). The resulting plasmid
is called pb510-HA-TCRb-GFP PTC+. The plasmid pb510-
HA-TCRb-GFPDJCin was generated by deleting the JC intron
using fusion PCR. Detailed cloning strategy and primer
sequences are available upon request. The HA-TCRb-GFP
gene of both plasmids was sequenced.
pSUPERpuro vector was created by inserting a puromycin-
resistance cassette lacking the HindIII site of the puromycin
ORF (from pTRE2pur, Clontech) into the XhoI site of
pSUPER (34). Sequences coding for short hairpin RNAs
(shRNAs) were inserted as double-stranded oligos into pSU-
PERpuro between the BglII and HindIII as described previ-
ously (34). The two target sequences of hUpf1 were
50-GAGAATCGCCTACTTCACT-30 (pSUPERpuro-hUpf1/I)
and 50-GATGCAGTTCCGCTCCATT-30 (pSUPERpuro-
hUpf1/II) and the two target sequences of hSmg6 were 50-
GGGTCACAGTGCTGAAGTA-30 (pSUPERpuro-hSmg6/I) and
50-GCTGCAGGTTACTTACAAG-30 (pSUPERpuro-hSmg6/II).
Cell culture and transfection
HeLa cells were grown in DMEM (Invitrogen) supplemented
with 10% heat inactivated fetal calf serum (FCS), 100 U/ml
penicillin and 100 mg/ml streptomycin. LipofectAmine
(Invitrogen) was used for all transient transfections according
to the manufacturer’s protocol. For RNAi experiments, cells
were seeded in 8 cm dishes and transfected with 2 mg empty
pSUPERpuro(mock),amixture of1mgpSUPERpuro-hUpf1/I
and 1 mg pSUPERpuro-hUpf1/II, or a mixture of 1 mg
pSUPERpuro-hSmg6/I and 1 mg pSUPERpuro-hSmg6/II
using 8 ml LipofectAmine (Invitrogen). An aliquot of
1.5 mg/ml puromycin (Calbiochem) was added to the cells
from 24 h post-transfection until the evening before analysis
(4 days post-transfection) to eliminate the untransfected cells.
Before analysis, the cells were cultured without puromycin for
at least 16 h to avoid potential effects of this translation inhib-
itor on NMD. In cells transfected with the empty pSUPER-
puro, relative levels of NMD substrates and mRNAs without a
PTC were identical irrespective of whether the cells were
treated with puromycin or not (data not shown), conﬁrming
that the puromycin treatment did not interfere with NMD. For
microscopy, 10 mm glass coverslips were placed in the culture
dish before seeding the cells.
To establish NMD reporter-expressing HeLa cell lines,
pb510-HA-TCRb-GFP PTC+ was transfected with Gene Jam-
mer Transfection Reagent (Stratagene) according to the man-
ufacturer’s instructions, and stable transfectants were selected
by cultivating the cells in the presence of 500 mg/ml of G418
(Geneticin, Invitrogen) for 2 weeks, before single cell clones
were isolated and expanded. As a control, stably transfected
clonalcelllineswerealsoestablishedusingareporterconstruct
that lacks the JC intron (pb510-HA-TCRb-GFP DJCin).
The monoclonal cell lines were treated with 100 mg/ml
cycloheximide (CHX) for 3 h to analyse the response of
NMDreportermRNAormRNA oftheDJCincontrolconstruct
to inhibition of NMD.
RNA analysis
Total cellular RNA was puriﬁed using the Absolutely RNA
RT–PCR Miniprep Kit (Stratagene) according to the manufac-
turer’s protocol. For real-time PCR analysis, 1 mg was reverse
transcribed in 50 ml Stratascript buffer in the presence of
200 ng random hexamers, 0.4 mM dNTP mix, 40 U RNasIn
(Promega) and 50 U Stratascript (Stratagene) according to the
manufacturer’s protocol. Reverse transcribed material corres-
ponding to 40 ng RNA was ampliﬁed in 25 ml Universal PCR
MasterMix, no AmpErase (Applied Biosystems) using the
following primers and TaqMan probes. TCR-b mRNA was
measured over the junction between the VDJ exon and the C1
exon using 400 nM forward primer om59 (50-GCGGTG-
CAGAAACGCTGTA-30), 400 nM reverse primer om60
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TaqMan probe TM59/60 (50-FAM-CTCGAGGATCTGA-
GAAATGTGACTCCACC-TAMRA-30). b-Globin mRNA
was measured over the junction between exons 2 and 3
using 800 nM forward primer om111 (50-GCTGCACTGTGA-
CAAGCTGC-30), 800 nM reverse primer om112 (50-AAAGT-
GATGGGCCAGCACAC-30) and 200 nM TaqMan probe
TM111/112 (50-FAM-TCCTGAGAACTTCAGGCTCCTG-
GGCAAC-TAMRA-30). hUpf1 mRNA, GAPDH mRNA
and 18S rRNA were measured using pre-developed assay
reagents from Applied Biosystems. For 18S rRNA measure-
ments, cDNA corresponding to 400 pg RNA instead of 40 ng
was used. Real-time PCR was run on the GeneAmp 5700 and
7000 Sequence Detection Systems (Applied Biosystems)
using the standard thermal proﬁle.
The conditions for the traditional endpoint RT–PCR shown
in Figure 1B were as follows: RNA was reverse transcribed
using an anchored primer against the poly(A) tail (50-N30-
VN-30) and Stratascript reverse transcriptase in Stratascript
ﬁrst strand buffer according to the manufacturer’s protocol
(Stratagene). Subsequent PCR was performed with a primer
binding to the HA-tag (om153; 50-TCCAGATTACGCTT-
CACTCGAAC-30) and a reverse primer binding to exon
C1 (om96; 50-GATGGCTCAAACAAGGAGACCTT-30).
An aliquot of the PCR was analysed on a 1.5% agarose gel
and stained with ethidium bromide.
For the northern blot shown in Figure 1C, 10 mg of total
cellular RNA was separated on a 1.2% agarose gel containing
1% formaldehyde and 1· MOPS. A picture of the ethidium
bromide stained gel before blotting was taken to use the 18S
rRNA band as loading control. The RNA was transferred to
positively charged nylon membrane (Roche Diagnostics) in
20· SSC by standard capillary blotting method. Probe label-
ling, hybridization, washing and signal detection was as
described elsewhere (32). Approximately 50 ng of a puriﬁed
SalI–BamHI fragment comprising the TCR-b minigene
sequence was used as template for the
32P-labelled probe.
Flow cytometry analysis
About 10
6 cells were harvested and resuspended in phosphate-
buffered saline (PBS)/1% FCS and then analysed using a
FACScan (BD, San Jose, CA). GFP ﬂuorescence was excited
at 488 nm and emission was measured with a 530/30 nm
bandpass ﬁlter. HeLa cells without the NMD reporter gene
(plain HeLa) served as a control for autoﬂuorescence and were
used to set the gate for GFP positive cells. The data were
processed using FlowJo software (Tree Star, Ashland, OR).
Figure 1. Expression of the HA-TCRb-GFP reporter gene yields correctly spliced mRNA. (A) Schematic representation of the NMD reporter gene. Sequences
derivedfromhumanb-actin,mouseTCR-bandEGFPareshowninwhite,yellowandgreen,respectively.Thehaemagglutininepitope(HA)isshowninpurple.The
positions of the transcription start site (+1), translation start codon (ATG), PTC and the normal stop codon (TGA) are depicted, and relevant restriction sites are
indicated. The intron deleted in the control construct DJCin is marked. See text for details. (B) RNA from HeLa cells transiently (tr) or stably (st) expressing the
HA-TCRb-GFPreportergene(PTC+)orthecontrolconstructwiththedeletedJCintron(DJCin)wasreversetranscribedandamplifiedwithprimersannealingtothe
firstandlastexon.RNAfromuntransfectedHeLacellsservedasanegativecontrol.ThePCRproductswereresolvedona1.5%agarosegel.(C)Analiquotof10mg
RNAfromHT1080cellsstablyexpressingtheHA-TCRb-GFPreportergene(PTC+)andfromuntransfectedHT1080cells(control)wasseparatedona1.2%agarose
gel. After ethidium bromide staining of the gel to reveal the ribosomal RNAs (see 18S rRNA loading control), the RNA was transferred to a nylon membrane and
hybridized with a
32P-labelled random-primed probe against TCRb. The position on the membrane of the 18S rRNA is marked on the right.
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Western blot analysis
Cells were lysed and denatured in SDS loading buffer and
these whole cell lysates were separated on 10% SDS–PAGE.
Proteins were then transferred to Optitran BA-S 85 reinforced
nitrocellulose (Schleicher & Schuell) and probed with differ-
ent antibodies. The monoclonal anti-HA mouse antibody
(BabCO, Berkeley, CA) was used at a dilution of 1:1000,
the anti-hUpf1 rabbit antiserum [(14), a kind gift from Jens
Lykke-Andersen] was diluted 1:2500, and supernatant of the
hybridoma cell line Y12 (producing the anti-Sm antibody) was
diluted 1:400. Horseradish peroxidase-conjugated anti-mouse
or anti-rabbit IgG antibody (Promega) was used as secondary
antibodies at a dilution of 1:2500, and detected with the
ECLplus Western Blotting Detection System (Amersham
Pharmacia Biotech).
Dual scanning microplate spectrofluorometer
Proteins were extracted in 1% deoxycholic acid, 1% NP40,
25 mM Tris–HCl (pH 8), 50 mM NaCl and protease inhibitor
cocktail (Complete Mini, EDTA-free; Roche). The cells were
incubated at4 Cfor 30 min on ashaker andthen centrifugedat
16 000 g for 5 min. The supernatant was immediately frozen in
liquid nitrogen and stored at  20 C. GFP ﬂuorescence was
measured on a SPECTRAmax Gemini (Molecular Devices)
using 96-well black plates with ﬂat, black bottom. GFP ﬂuor-
escence was excited at 488 nm and measured at 512 nm, the
cut-off was set at 495 nm. SOFTmaxPRO software was used
for data analysis.
Confocal microscopy
Images were collected on a Leica TCS SP2 AOBS laser
scanning confocal microscope equipped with a HCX PL
APOlbd.BL 63.0· 1.2W objective (Leica Microsystems
Inc., Exton, PA). The cells were grown on coverslips, washed
once with PBS and then ﬁxed in 4% paraformaldehyde and
mounted on DAKO ﬂuorescent anti-fading mounting medium
(DAKO Corporations). For GFP detection, cells were scanned
using the 488 nm laser line and emitted light between 500 and
600 nm was collected. The pinhole was opened to 418 mm and
the photomultipliers were set to 580 V. The same settings for
image acquisition and processing have been applied for all
samples to allow comparison of the ﬂuorescence intensities
among the different samples.
RESULTS AND DISCUSSION
Design of the NMD reporter gene
Fluorescent proteins have become a valuable tool for
innumerable applications in modern biology, because the
light emitted by these proteins can be detected relatively easily
by many different techniques. Therefore, we decided to
develop a reporter system for NMD that is based on the
enhanced green ﬂuorescent protein (EGFP, Clontech). To
this end, we inserted the EGFP ORF in frame into the middle
exon of a TCR-b minigene (Figure 1A). In this position, more
than 50 ntupstreamof the 30-most50-splice site, the stop codon
of the EGFP ORF is recognized as a PTC and, thus, the mRNA
is subjected to NMD. A TCR-b minigene was chosen for our
reporter gene, (i) because NMD of TCR-b transcripts has been
extensively studied and (ii) because PTCs in these TCR-b
minigenes cause a dramatic reduction in the steady-state
mRNA levels (35,36). The particular TCR-b minigene used
here has fused the ﬁrst 120 bp of exon C1 to base pair number
117 of exon C4 and, therefore, lacks part of the constant
region. Since the signal peptide encoded by the Vleader exon
is still present in this TCR-b minigene, while the region of
the gene encoding the membrane-spanning domain is missing,
it was likely that this TCRb-GFP protein would be secreted
from the cells. To prevent this potential problem, and to
introduce a tag that allows easy detection of the TCRb-GFP
protein in western blots, we replaced the signal peptide encod-
ing sequence in the Vleader exon with a sequence encoding for
the haemagglutinin epitope (Figure 1A, HA-tag).
In addition, a control construct was derived from the NMD
reportergenebydeletingthesecondintron(Figure1A,DJCin).
This DJCin construct encodes the same TCRb-GFP fusion
protein as the NMD reporter construct, but because the
PTC in the DJCin construct is now located in the last exon,
its mRNA is not expected to be a substrate for NMD.
In RNA samples from HeLa cells stably or transiently
expressing the TCRb-GFP reporter gene, we ampliﬁed by
RT–PCR a product of the size expected for the correctly
spliced mRNA (Figure 1B), indicating that insertion of the
EGFP ORF into the VDJ exon, which results in an unusually
long internal exon, did not induce alternative splicing of
the pre-mRNA. Correct splicing was also conﬁrmed for the
DJCin construct stably expressed in HeLa cells (Figure 1B),
and for the NMD reporter gene stably expressed in the diploid
human cell line HT1080: northern blotting revealed a single
and speciﬁc band for HA-TCRb-GFP mRNA in the expected
size range (Figure 1C). We conclude that the vast majority of
HA-TCRb-GFP transcripts are spliced correctly in human
cells, both when expressed episomally (transient transfection)
or from a genomic locus (stable transfection).
The GFP fluorescence is proportional to the mRNA
level of the reporter gene
TheconceptofaGFP-based NMDreporter system isto usethe
GFP ﬂuorescence as a measure for the steady-state mRNA
level of the NMD reporter. Thus, the reporter system is only
useful, if the intensity of the GFP ﬂuorescence is proportional
to the mRNA level. To test this, HeLa cells were transfected
with increasing amounts of NMD reporter plasmid DNA.
Seventy-two hours post-transfection, a fraction of the cells
was analysed by ﬂow cytometry (Figure 2A), and from the
restofthe cells, RNAwasisolatedandrelative reporter mRNA
levels were measured by real-time RT–PCR. The comparison
betweenthe percentageofGFP-positivecellsmultipliedbythe
average intensity of GFP ﬂuorescence (Figure 2B) and the
relative reporter mRNA levels (Figure 2C) for the different
plasmid DNA amounts shows that the GFP signal is indeed
highly proportional to mRNA levels.
The same experiment was also carried out with the DJCin
controlconstruct,andtherespective GFPsignals (mean ﬂuore-
scence intensity multiplied by percentage of GFP-positive
cells) are shown in comparison with the GFP signals determ-
ined for the PTC+ construct (Figure 2D). With increasing
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NMD reporter construct changes from 9-fold lower than the
GFP signal of the NMD-resistant control construct to only
3-fold lower. The extent of NMD cannot be determined accur-
ately from this experiment fortwo reasons. When low amounts
ofplasmidDNAistransfected, mostoftheresultingweakGFP
signals will be hidden within the autoﬂuorescence of the cells,
and only a small percentage of the cells qualiﬁes as ‘GFP
positive’ (ﬂuorescence signal distinct from the autoﬂuore-
scence seen in the mock-transfected control cells) and contri-
butes to the overall GFP signal. Because this effect is more
pronounced for the PTC+ than for the DJCin, the extent of
NMD will be overestimated with low plasmid DNA amounts.
On the other hand, we know from experience with a number
of different NMD reporter genes that NMD can easily be
saturated by the expression of high amounts of NMD substrate
(A. Paillusson and O. Mu ¨hlemann, unpublished data). This
partially saturated NMD results in a decreased difference
between the PTC+ and the DJCin GFP signal measured
with high plasmid DNA amounts. Taking both effects into
consideration, we estimate that non-saturated NMD reduces
the ﬂuorescence of our TCRb-GFP fusion protein expressed
from the NMD reporter construct  4- to 6-fold.
Establishing cell lines stably expressing
the NMD reporter
After having conﬁrmed that the GFP signal proportionally
reﬂects the mRNA level of the NMD reporter, we transfected
HT1080 (data not shown) and HeLa cells with our NMD
reporter plasmid and selected a number of single cell clones
that had integrated the reporter gene into the genome. In order
to select a suitable NMD reporter system, we ﬁrst screened the
monoclonal cell lines by real-time RT–PCR for lines express-
ing a clearly detectable level of the HA-TCRb-GFP reporter
mRNA, which allowed us to eliminate ‘false positives’ that
did not express the reporter gene at all (data not shown). Cell
lines expressing the reporter gene were then treated with the
translation inhibitor CHX for 3 h, which is a standard way to
inhibit NMD (31), and the increase in reporter mRNA levels
was quantiﬁed by real-time RT–PCR. As a control, we also
generated and analysed in parallel stably transfected clonal
cell lines expressing the DJCin construct. Because this con-
struct lacks an intron downstream of the PTC, its mRNA
should not be subjected to NMD. Figure 3 shows the relat-
ive mRNA levels of a NMD reporter-expressing cell line
(left panel) and of a cell line expressing the DJCin control
construct (right panel) after the inhibition of NMD with CHX.
The NMD reporter mRNA increased on average 6.5-fold
upon CHX treatment, similar to the previously tested
PTC-containing TCR-b minigenes (37), whereas the mRNA
level of the DJCin control construct increased only slightly,
conﬁrming that this is not a substrate for NMD.
RNAi-mediated depletion of hUpf1 and hSmg6
causes increased mRNA and protein levels of
the NMD reporter gene
Treatment of cells with CHX is an easy and quick way to
inhibit NMD, but because it blocks all cellular translation,
unspeciﬁc effects inﬂuencing the level of NMD reporter
mRNA could also occur. Therefore, we decided to interfere
with NMD speciﬁcally by knocking down essential NMD
factors using RNAi techniques. To this end, we used the
pSUPER plasmid (34), from which RNAi-inducing shRNAs
can be expressed. To be able to use such a transfection-based
RNAi approach for subsequent biochemical analysis, an
almost 100% transfection efﬁciency or a way to eliminate
untransfected cells before analysis is required. Since the ﬁrst
option is not always feasible, we opted for the second and
introduced into the pSUPER vector the puromycin resistance
gene, which allows elimination of the untransfected cells
during the course of the RNAi experiment (see Materials
and Methods). The NMD reporter gene-expressing HeLa
cell line was transfected with such pSUPERpuro plasmids
encoding shRNAs against the two essential human NMD
factors hUpf1 (12,13,38) or hSmg6 [also called hEST1A
or Smg5/7a (18–20)], and the effect on the reporter mRNA
level was analysed(Figure4). Compared with cellstransfected
with the empty pSUPERpuro (Mock), mRNA levels of
the NMD reporter increased between 6- and 11-fold when
hUpf1 was knocked down by RNAi (Figure 4A, left panel,
and Figure 4C), whereas the DJCin mRNA level in the control
cell lines was not affected (Figure 4A, right panel). While
RNAi against hUpf1 worked quite efﬁciently, resulting in
a 10-fold or greater reduction of hUpf1 mRNA (Figure 4C,
anddatanotshown)andbarely detectablehUpf1proteinlevels
(Figure 4B) under our experimental conditions, RNAi against
hSmg6 resulted only in a  3-fold reduction of hSmg6 mRNA
in our hands (Figure 4C, and data not shown). Yet, this mod-
eratereductionofhSmg6levelscausedthesameincreaseofthe
NMD reporter mRNA as knockdown of hUpf1 (Figure 4C).
This result suggests that hSmg6 might be a limiting factor for
NMD function. Collectively, these results show that the
expression of our NMD reporter gene increases as predicted
when NMD deﬁciency is induced by RNAi.
Detection of NMD deficiency by flow cytometry
In order to use the NMD reporter system as a tool for screening
large number of cells for NMD deﬁciency, its readout (i.e.
GFP ﬂuorescence) should be detectable by techniques capable
of analyzing many cells within a short time. To detect and
isolate NMD-deﬁcient cells in a large cell population, ﬂow
cytometry is today’s method of choice. To test the suitability
of our NMD reporter system for analysis by ﬂow cytometry,
we knocked down hUpf1 and hSmg6 in the reporter gene-
expressing HeLa cell line as in the previous experiment
and determined the ﬂuorescence emitted by these cells using
FACScan. As a reference signal for GFP in NMD-competent
cells, the reporter cell line was transfected with the empty
pSUPERpuro (Mock), and to control for autoﬂuorescence
of the cells, mock-transfected parental HeLa cells were also
analysed.The two cellpopulations with RNAi-mediated NMD
deﬁciency exhibited clearly more GFP ﬂuorescence than the
mock-transfected reporter cell line, demonstrating that ﬂow
cytometry can be used to analyse the NMD reporter system
(Figure 5A). In the mock-transfected reporter cells, almost no
GFP signal could be detected over the background caused
by the autoﬂuorescence, similar to the situation when small
amounts of NMD reporter gene were transiently expressed
(Figure 2A). Since almost no GFP signal over background
could be detected in mock-transfected reporter cells, the
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calculated. As a control, NMD reporter mRNA levels were
measured from the same cells analysed by ﬂow cytometry. As
in previous experiments (Figure 4C), the RNAi-mediated
knockdown of hUpf1 and hSmg6 resulted in an  10-fold
increase of reporter mRNA (Figure 5B). RNA from the
mock-transfectedparentalHeLacellsgavenodetectablesignal
in the real-time RT–PCR assay, conﬁrming that the TaqMan
probe for measuring reporter mRNA is speciﬁc (data not
shown). In summary, this experiment shows that our NMD
reporter system can be used in conjunction with ﬂow cyto-
metry to detect NMD-deﬁcient cells.
Detection of NMD deficiency using a microplate
spectrofluorometer
For other types of automated large-scale screens, the preferred
analysis method includes the use of a ﬂuorescence plate
reader. A typical example for such an application would be
a screening of chemical libraries for compounds that inhibit
NMD. Although the nature of the reporter system would pre-
vent the identiﬁcation of compounds that inhibit NMD by
blocking translation, it might still be very useful to identify
novel compounds that inhibit NMD through other mechan-
isms, such as binding to essential NMD factors. We, therefore,
wanted to test whether our NMD reporter cells can be used to
detect NMD deﬁciency by measuring the GFP ﬂuorescence in
whole cell extracts using a microplate spectroﬂuorometer
(SpectraMAX Gemini). To this end, hUpf1 was again knocked
Figure 3. NMD reporter mRNA stably expressed in a single-cell clone
increases upon inhibition of translation by CHX treatment. After transfection
of HeLa cells with the NMD reporter gene (HA-TCRb-GFP PTC+) or with the
control construct (HA-TCRb-GFP DJCin) and selection for G418 resistance,
cell lines derived from single-cell clones were established. RNA was isolated
from these cell lines after treatment with 100 mg/ml cycloheximide for 3 h
(+CHX) or without CHX treatment (no CHX). Relative NMD reporter mRNA
was measured by real-time RT–PCR and normalized to relative GAPDH
mRNA levels. For each cell line, the NMD reporter mRNA level of non-
treated cells was set to 100 and the mRNA level of the CHX treated cells is
shown relative to it. Average values and standard errors of five real-time PCR
runs are shown.
Figure 2. The GFP fluorescence is proportional to the mRNA level of the reporter gene. (A) Forty-eight hours after transfection with the indicated amounts of the
HA-TCRb-GFPreportergenetogetherwithaconstantamountofa b-globin-expressingplasmid(41),theHeLacells wereanalysedbyflowcytometry.Thegatefor
GFPpositivecellswassetsothattheautofluorescenceofthemock-transfectedcellsdidnotscoreasGFPpositive.MFI,meanfluorescenceintensity.(B)MFIvalues
multipliedwiththepercentageofGFPpositivecellsfrom(A)wereplottedagainsttheamountoftransfectedNMDreporterplasmidDNA.(C)Fromanaliquotofthe
cells used in (A), RNA was isolated and relative NMD reporter mRNA and b-globin mRNA was measured by real-time RT–PCR. Relative reporter mRNA levels
were normalized to relative b-globin mRNA levels, and average values and standard deviations of three real-time PCR runs are shown. (D) Analogous to the
experimentshownin(A)and(B)forthePTC+reportergene,theGFPsignalsfromcellstransientlytransfectedwithdifferentamountsoftheDJCincontrolconstruct
were determined by flow cytometry. As in (B), the GFP signal is defined as MFI* % of GFP positive cells.
Figure 4. RNAi-mediated knockdown of essential NMD factors results in the
expected increase of NMD reporter mRNA. (A) HeLa cell lines stably
expressing the HA-TCRb-GFP reporter construct (PTC+) or the control
construct lacking the JC intron (DJCin) were transfected with pSUPERpuro
plasmids expressing shRNAs against hUpf1, or with the empty pSUPERpuro
(mock) as a control. After eliminationof the non-transfected cells by treatment
with puromycin, RNA was isolated 4 days post-transfection and relative NMD
reportermRNAwasmeasuredbyreal-timeRT–PCRandnormalizedtorelative
GAPDH mRNA levels. Average values of three PCR runs from a typical
experiment are shown. (B) The hUpf1 knockdown in the cells used in (A)
wasmonitoredbyawesternblotusinghUpf1-specificpolyclonalantisera.Cell
extract of untransfected HeLa cells was used as a reference in the first lane.
Detection of Sm proteins B/B0 with the monoclonal antibody Y12 served as
loading control. (C) Average reporter mRNA levels determined from three
independent knockdowns of hUpf1 or hSmg6 in the cell line expressing the
NMD reporter construct (PTC+). The relative reporter mRNA levels were
measured by real-time RT–PCR and normalized to relative GAPDH mRNA
levels. Relative hUpf1 and hSmg6 mRNA levels were also determined to
monitortheefficiencyoftheknockdowns.hUpf1mRNAwas 10-foldreduced
compared with the mock, and hSmg6 mRNA  3-fold (data of one typical
experiment is shown).
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reporter cells and mock-transfected plain HeLa cells were
used as controls. Whole cell extracts of each cell population
were prepared and the ﬂuorescence at 512 nm (GFP) of dif-
ferent dilutions thereof was measured. The values obtained
with the NMD reporter cells were normalized by subtracting
the background values measured with plain HeLa (Figure 6A).
Very similar to the result of the ﬂow cytometry analysis, no
GFP signal signiﬁcantly over background could be detected in
the NMD-competent, mock-transfected reporter cells, even
with an amount of cell lysate corresponding to 10
6 cells. In
contrast, a linear increase of GFP ﬂuorescence, proportional to
the amount of lysate used, was readily detected in reporter
cells where hUpf1 was knocked down. This demonstrates that
Figure 6. Detection of NMD deficiency by spectrofluorometry. (A) The GFP
signal in extract corresponding to the indicated amount of cells from mock-
transfected (black circles) and pSUPERpuro-hUpf1 transfected NMD reporter
cells (grey squares), and from plain HeLa cells was measured with a dual
scanning spectrofluorometer. The values measured in plain HeLa were used
to subtract the background. RNAi was performed as in Figure 4. (B) Aliquots
of the cells used in (A) were checked by western blotting using antibodies
against hUPF1 (14) and the HA-tag to monitor the knockdown efficiency and
the increase of the NMD reporter protein level, respectively. The two Sm
proteins B and B0, detected with the monoclonal antibody Y12, served as
loading control.
Figure 5. DetectionofincreasedGFPfluorescence byflowcytometryanalysis
after RNAi-mediated knockdown of NMD factors. (A) hUpf1 or hSmg6
was knocked down in the NMD reporter gene-expressing HeLa cells as
in Figure 4, and the cells were analysed by flow cytometry 4 days post-
transfection. (B) From an aliquot of the same cells used for flow cytometry,
relativereportermRNAlevelsweredeterminedbyreal-timeRT–PCR.Average
numbers of four PCR runs, normalized to endogenous GAPDH mRNA levels,
are shown.
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combination with a ﬂuorescence plate reader. However, the
minimal amount of lysate required to detect a GFP signal
clearly over background in the hUPF1-depleted cells corres-
ponds to  4 · 105 cells, which is too much for a large-scale
screening. Thus, in order to use the NMD reporter system for
spectroﬂuorometer-based drug discovery, the sensitivity of the
assay needs to be improved (see below).
To assess the efﬁciency of the hUpf1 knockdown and its
effect on the level of reporter protein, aliquots of the cells
used in Figure 6A were analysed by western blot analysis
(Figure 6B). Probing with the anti-hUPF1 antibody shows
that inthisexperiment too,the expression ofshRNAs targeting
hUpf1 mRNA led toa strongreductioninhUPF1 protein. With
the anti-HA antibody, NMD reporter protein could be detected
in the hUpf1 knockdown cells, but not in the mock-transfected
cells, consistent with result from the spectroﬂuorometer. The
monoclonalantibodyY12,whichdetectstheSmproteinsB,B0,
D1 and D3 (39), was used as a loading control. Real-time RT–
PCR showed that the NMD reporter mRNA levels increased
3.2-fold in this particular experiment (data not shown).
Detection of NMD-deficiency by fluorescence
microscopy
The third detection method that we tested on our NMD
reporter cells was ﬂuorescence microscopy using a confocal
laser scanning microscope. As previously, hUpf1 was knocked
down in the NMD reporter-expressing HeLa cell line by trans-
fection of hUpf1 targeting pSUPERpuro followed by selection
of the puromycin-resistant cells. Four days after transfection,
these cells were examined under the ﬂuorescence microscope
and compared with the mock-transfected, NMD-competent
reporter cells and untransfected HeLa cells. Only weak
green ﬂuorescence could be detected mainly in the cytoplasm
of mock-transfected reporter cells when the pinhole of the
confocal microscope was opened to achieve maximal sensit-
ivity (Figure 7D). The average ﬂuorescent signal was never-
theless signiﬁcantly higher than the autoﬂuorescence seen
in untransfected HeLa cells (Figure 7B), and we therefore
conclude that in contrast to ﬂow cytometry (Figure 5A), the
low basal GFP level of the NMD reporter can be detected by
laser scanning ﬂuorescence microscopy. In contrast to this low
basal level of GFP in the mock-transfected reporter cells, the
green ﬂuorescence, which is predominantly cytoplasmic, is
much more intense of hUPF1-depleted reporter cells (compare
Figure 7D and F). Differential interference contrast (DIC)
images of the same cells showed no obvious morphological
changes 4 days after transfection of pSUPERpuro plasmids
(compare Figure 7C and E with Figure 7A), suggesting that
at this time point, abrogation of NMD has not yet severely
damaged the cells (see below). We conclude that our NMD
reporter system can also be used to screen for individual cells
by ﬂuorescence microscopy.
CONCLUSIONS
Here, we describe the construction of a GFP-based reporter
system, in which increased green ﬂuorescence of the cells
signals NMD deﬁciency. We validate this reporter system
by demonstrating that increased GFP signals are in fact
detected by ﬂow cytometry, spectroﬂuorometry and ﬂuore-
scence microscopy in cells, where NMD has been abrogated
by knocking down essential NMD factors using RNAi tech-
niques. In all these tests, our NMD reporter system behaved as
expected, proving its potential to become a valuable tool for
future studies of NMD.
If the GFP-based NMD reporter system is used to screen for
NMD-deﬁcient cells, one must be aware that, for example,
mutants that enhance transcription or translation, or that
inhibit general mRNA turnover or protein degradation will
also result in increased GFP ﬂuorescence. To identify such
false positives, samples with increased GFP signal must there-
fore be validated by further experiments. To this end, reporter
mRNA levels and mRNA of an endogenous gene can be
measured, and in addition, expression and analysis of another
well-established NMD reporter mRNA can be used to conﬁrm
NMD deﬁciency.
For some automated large-scale screenings, the currently
generally low GFP signal emitted by the reporter may limit its
application. However, there are several ways to improve the
sensitivity of the system if required. On the one hand, detec-
tionsystemsarebecomingmoreandmoresensitive,andonthe
other hand, it should be possible to generate cell lines that
contain more copies of the HA-TCRb-GFP gene and, thus,
would be expected to generate more ﬂuorescence per cell.
For ﬂow cytometry applications, substitution of GFP in our
reporter gene by another ﬂuorescent protein variant that emits
light at a different wavelength might overcome the current
problem of low GFP signals being hidden in the autoﬂuore-
scence of the cells (Figures 2A and 5A). To increase the
sensitivity of the reporter system in spectroﬂuorometric
applications, GFP could be replaced by ﬁreﬂy luciferase.
Because luciferase produces chemiluminescence in an enzym-
atic reaction by oxidation of luciferin, detection of more light
per reporter molecule would be expected when using a micro-
plate spectroﬂuorometer.
In parallel to the HeLa NMD reporter system mainly
described here, we have also generated a diploid HT1080
cell line that expresses our NMD reporter gene (Figure 1C,
and data not shown) and used these cells for a mutagenesis
screen with the goal of obtaining NMD-deﬁcient cell lines.
The mutagenesis scheme and the selection of high GFP-
expressing cells by ﬂow cytometry was essentially as
described for a similar screen, which yielded mutant cell
clones deﬁcient for rapid ARE-dependent IL-3 mRNA turn-
over (26). Although high GFP-expressing cells occurred at a
very low frequency in our mutated cell population, we were
never able to proliferate the high GFP-expressing cells after
sorting (data not shown). This was not due to cell culturing
problems, because from the mutated cell pool, cell lines from
single, low GFP-expressing cells could be obtained with a
reasonable plating efﬁciency (data not shown). Meanwhile,
we believe that the reason for the failure of this mutagenesis
screen might be that NMD could be essential for survival of
mammalian cells, even in cell culture. In our RNAi experi-
ments targeting hUpf1 and hSmg6, the cells die 7–8 days after
transfection (A. Paillusson and O. Mu ¨hlemann, unpublished
data). In addition, from all attempts to stably transfect pSU-
PERpuro targeting hUpf1, we only obtained cell clones in
which the hUpf1 protein level was reduced 5-fold or less
(data not shown), while hUpf1 is usually reduced  10-fold
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plasmids are assayed 4 or 5 days after transfection (Figures 4B
and 6B, and data not shown). Furthermore, Upf1 knock-out is
lethal in mice, with embryos dying 6–7 days post coitus (40).
All these observations are consistent with the suggestion that
NMD might be essential for viability of mammalian cells.
However, it is also possible that hUpf1 and hSmg6 play addi-
tional roles in other essential cellular processes.
Figure 7. Detection of NMD deficiency by confocal laser scanning fluorescence microscopy. The NMD reporter cell line was grown on coverslips and transfected
with the empty pSUPERpuro plasmid (mock; C and D) or with pSUPERpuro-Upf1 (E and F) as in Figure 4. Untransfected HeLa cells served as a control for
background autofluorescence (A and B). After fixation, the cells were analysed using a confocal laser scanning fluorescence microscope. Differential interference
contrast (DIC) images (A, C and E) and fluorescence images in the GFP channel (B, D and E) of the same cells are shown.
e54 Nucleic Acids Research, 2005, Vol. 33, No. 6 PAGE 10 OF 12In conclusion, the GFP-based NMD reporter gene system
described here faithfully reports NMD deﬁciency in individual
cells by increasing the ﬂuorescence of these cells. Because the
NMD reporter system functions in combination with ﬂow
cytometry, spectroﬂuorometry and ﬂuorescence microscopy,
it has the potential to be used for automated large-scale
screening applications, although some modiﬁcations might be
necessary for speciﬁc applications (see above). With these
properties, this NMD reporter gene system represents a new
and valuable tool in the toolbox of researchers investigating
the molecular mechanisms of mammalian NMD.
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